Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masao Koida

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 17, 2003
[Pharmacotherapy of osteoporosis]Masao Koida
Current Pharmaceutical Design|August 24, 2004
Osteoporosis requires bone-specific statinsMasao Koida, Ryo Fukuyama, Hiromichi Nakamuta
The Journal of Biological Chemistry|April 17, 2002
New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMPTakashi Fujita, Toru Meguro, Ryo Fukuyama, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 21, 2002
[Anti-osteopenic effect of taurine: possible involvement of activated MEK-ERK-Cbfa1 signaling]Chigusa Yasutomi, Hiromichi Nakamuta, Takashi Fujita, et al.
Biochemical and Biophysical Research Communications|February 21, 2004
Statins inhibit osteoblast migration by inhibiting Rac-Akt signalingRyo Fukuyama, Takashi Fujita, Yasutaka Azuma, et al.
The Journal of Cell Biology|July 1, 2004
Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signalingTakashi Fujita, Yasutaka Azuma, Ryo Fukuyama, et al.
Journal of Pharmacological Sciences|May 25, 2011
Anti-osteoporosis effect of 5-bromo-2-(4-chlorobenzoyl)-(Z)-3-(2-cyano-3-hydroxybut-2-enonyl)aminobenzo[b]furan: a novel selective estrogen receptor modulatorRyo Fukuyama, Akio Shimokawa, Yasushi Kodama, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2006
A novel oxazine ring closure reaction affording (Z)-((E)-2-styrylbenzo[b]furo[3,2-d][1,3]oxazin-4-ylideno)acetaldehydes and their anti-osteoclastic bone resorption activityYuko Ando, Kumiko Ando, Mami Yamaguchi, et al.
Bioorganic & Medicinal Chemistry|May 2, 2009
Preparation of novel (Z)-4-ylidenebenzo[b]furo[3,2-d][1,3]oxazines and their biological activityYukako Tabuchi, Yuko Ando, Hidemi Kanemura, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 17, 2003
[Pharmacotherapy of osteoporosis]Masao Koida
Current Pharmaceutical Design|August 24, 2004
Osteoporosis requires bone-specific statinsMasao Koida, Ryo Fukuyama, Hiromichi Nakamuta
The Journal of Biological Chemistry|April 17, 2002
New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMPTakashi Fujita, Toru Meguro, Ryo Fukuyama, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 21, 2002
[Anti-osteopenic effect of taurine: possible involvement of activated MEK-ERK-Cbfa1 signaling]Chigusa Yasutomi, Hiromichi Nakamuta, Takashi Fujita, et al.
Biochemical and Biophysical Research Communications|February 21, 2004
Statins inhibit osteoblast migration by inhibiting Rac-Akt signalingRyo Fukuyama, Takashi Fujita, Yasutaka Azuma, et al.
The Journal of Cell Biology|July 1, 2004
Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signalingTakashi Fujita, Yasutaka Azuma, Ryo Fukuyama, et al.
Journal of Pharmacological Sciences|May 25, 2011
Anti-osteoporosis effect of 5-bromo-2-(4-chlorobenzoyl)-(Z)-3-(2-cyano-3-hydroxybut-2-enonyl)aminobenzo[b]furan: a novel selective estrogen receptor modulatorRyo Fukuyama, Akio Shimokawa, Yasushi Kodama, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2006
A novel oxazine ring closure reaction affording (Z)-((E)-2-styrylbenzo[b]furo[3,2-d][1,3]oxazin-4-ylideno)acetaldehydes and their anti-osteoclastic bone resorption activityYuko Ando, Kumiko Ando, Mami Yamaguchi, et al.
Bioorganic & Medicinal Chemistry|May 2, 2009
Preparation of novel (Z)-4-ylidenebenzo[b]furo[3,2-d][1,3]oxazines and their biological activityYukako Tabuchi, Yuko Ando, Hidemi Kanemura, et al.
Pageof 1